Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

SELL
$350.25 - $422.63 $356,904 - $430,659
-1,019 Reduced 4.94%
19,625 $7.03 Billion
Q2 2023

Aug 14, 2023

SELL
$359.49 - $486.4 $2.7 Million - $3.66 Million
-7,515 Reduced 26.69%
20,644 $7.83 Billion
Q1 2023

May 15, 2023

BUY
$418.69 - $503.0 $1.8 Million - $2.16 Million
4,295 Added 18.0%
28,159 $13.5 Billion
Q4 2022

Feb 13, 2023

BUY
$351.71 - $456.01 $8.39 Million - $10.9 Million
23,864 New
23,864 $10 Billion

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.42B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Rivermont Capital Management LP Portfolio

Follow Rivermont Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rivermont Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Rivermont Capital Management LP with notifications on news.